Dr. Michele T. Pritchard, Assistant Professor, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, will present the seminar "An emerging role for the hyaluronan in the pathogenesis of liver fibrosis" on Tues. Oct. 15, 2013 at 4:00 PM in N172 Beadle Center.
Michele Pritchard is a new Assistant Professor recruited in August of 2012 to the University of Kansas Medical Center from Case Western Reserve University and the Cleveland Clinic, in Cleveland, Ohio. Dr. Pritchard’s research is focused on identifying novel mechanisms which contribute to hepatic fibrosis, a disease for which there is currently no cure. In one project, Dr. Pritchard’s lab is trying to elucidate how the transcription factor, early growth response-1 exerts anti-fibrotic function in liver. In the second project, about which she will speak during her seminar in the Center for Biological Chemistry and Redox Biology Center on 15 October, she will discuss her very recent findings that suggest a potent modulatory role for hyaluronan, an extracellular matrix glycosaminoglycan, in the hepatic fibrotic response.